Group One Trading’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.56K | Sell |
300
-8,300
| -97% | -$173K | ﹤0.01% | 6612 |
|
|
2026
Q1 | $201K | Sell |
8,600
-400
| -4% | -$8.69K | ﹤0.01% | 4103 |
|
|
2025
Q4 | $189K | Buy |
9,000
+4,000
| +80% | +$69.8K | ﹤0.01% | 4418 |
|
|
2025
Q3 | $76.9K | Sell |
5,000
-3,200
| -39% | -$41.9K | ﹤0.01% | 5574 |
|
|
2025
Q2 | $76.8K | Buy |
8,200
+7,500
| +1,071% | +$82.5K | ﹤0.01% | 5206 |
|
|
2025
Q1 | $8.6K | Buy |
700
+100
| +17% | +$1.41K | ﹤0.01% | 6357 |
|
|
2024
Q4 | $7.93K | Sell |
600
-39,600
| -99% | -$678K | ﹤0.01% | 6213 |
|
|
2024
Q3 | $774K | Buy |
40,200
+38,700
| +2,580% | +$800K | ﹤0.01% | 2517 |
|
|
2024
Q2 | $30.8K | Sell |
1,500
-42,100
| -97% | -$881K | ﹤0.01% | 4901 |
|
|
2024
Q1 | $1.04M | Sell |
43,600
-23,000
| -35% | -$513K | ﹤0.01% | 2053 |
|
|
2023
Q4 | $1.44M | Sell |
66,600
-648,600
| -91% | -$9.97M | ﹤0.01% | 2135 |
|
|
2023
Q3 | $10.4M | Buy |
715,200
+703,300
| +5,910% | +$13.3M | 0.03% | 511 |
|
|
2023
Q2 | $249K | Buy |
11,900
+2,400
| +25% | +$50K | ﹤0.01% | 3713 |
|
|
2023
Q1 | $201K | Sell |
9,500
-1,900
| -17% | -$47.3K | ﹤0.01% | 3671 |
|
|
2022
Q4 | $290K | Buy |
+11,400
| New | +$266K | ﹤0.01% | 3525 |
|
|
2022
Q2 | – | Sell |
-100
| Closed | -$2K | – | 8480 |
|
|
2022
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 7751 |
|
|
2021
Q4 | $2K | Buy |
+100
| New | +$1.85K | ﹤0.01% | 7906 |
|
|
2021
Q3 | – | Sell |
-6,300
| Closed | -$108K | – | 8746 |
|
|
2021
Q2 | $108K | Buy |
6,300
+6,200
| +6,200% | +$114K | ﹤0.01% | 5873 |
|
|
2021
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 7398 |
|
|
2020
Q4 | $2K | Sell |
100
-12,500
| -99% | -$259K | ﹤0.01% | 6269 |
|
|
2020
Q3 | $186K | Buy |
12,600
+5,000
| +66% | +$76.2K | ﹤0.01% | 3706 |
|
|
2020
Q2 | $113K | Buy |
7,600
+6,700
| +744% | +$102K | ﹤0.01% | 3803 |
|
|
2020
Q1 | $10K | Sell |
900
-9,300
| -91% | -$87.3K | ﹤0.01% | 4576 |
|
|
2019
Q4 | $90K | Buy |
10,200
+5,200
| +104% | +$38.2K | ﹤0.01% | 3707 |
|
|
2019
Q3 | $37K | Sell |
5,000
-1,000
| -17% | -$9.11K | ﹤0.01% | 4120 |
|
|
2019
Q2 | $56K | Buy |
6,000
+1,700
| +40% | +$12.4K | ﹤0.01% | 3713 |
|
|
2019
Q1 | $23K | Hold |
4,300
| – | – | ﹤0.01% | 3963 |
|
|
2018
Q4 | $19K | Sell |
4,300
-12,000
| -74% | -$65.8K | ﹤0.01% | 4048 |
|
|
2018
Q3 | $132K | Buy |
16,300
+15,300
| +1,530% | +$109K | ﹤0.01% | 3325 |
|
|
2018
Q2 | $7K | Buy |
1,000
+500
| +100% | +$4.91K | ﹤0.01% | 4731 |
|
|
2018
Q1 | $7K | Sell |
500
-500
| -50% | -$5.31K | ﹤0.01% | 4428 |
|
|
2017
Q4 | $9K | Buy |
+1,000
| New | +$9.9K | ﹤0.01% | 4415 |
|
Other funds holding SNDX
KCM
DM
EP
HRCM
Group One Trading's SNDX Position: Q2 2026 in Review
Group One Trading opened a new position in Syndax Pharmaceuticals (SNDX) in Q2 2026: 4,861 shares worth $106K. The stake represents ﹤0.01% of the portfolio and ranks #4801 among its holdings. This is a return to the name: Group One Trading previously reported a position in SNDX as recently as Q4 2025.
Group One Trading first reported a position in SNDX in Q4 2017 and has held it in 21 quarters since. The position peaked at $1.64M in Q3 2023. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.
- Group One Trading held 4,861 shares of Syndax Pharmaceuticals worth $106K as of Q2 2026.
- Syndax Pharmaceuticals was a new Group One Trading position in Q2 2026.
- Syndax Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4801 holding.
- Group One Trading first reported a position in Syndax Pharmaceuticals in Q4 2017 and has held it in 21 quarters since.
- Group One Trading's Syndax Pharmaceuticals position peaked at $1.64M in Q3 2023.
- 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.